Clinical trial

Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma

NCT00186888 · St. Jude Children's Research Hospital, Other · Completed

Key facts

NCT number NCT00186888
Title Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
Official title Protocol for the Study and Treatment of Patients With Intraocular Retinoblastoma
Lead sponsor St. Jude Children's Research Hospital, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Retinoblastoma, Retinal Neoplasm
Intervention type Drug, Other, Procedure, Radiation
Interventions Enucleation, Vincristine, Carboplatin, Focal Therapies, External Beam Radiation, Vincristine and Topotecan, Vincristine + Carboplatin + Etoposide, vincristine, cyclophosphamide, and doxorubicin and 3 more
Enrollment 107
Start date Apr 7, 2005
Primary completion Nov 1, 2013
Completion Nov 12, 2024
First posted Sep 16, 2005
Last update posted Sep 4, 2025
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies